This suggests that these are being increasingly used off-label for weight loss and other non-diabetes indications
Summary Keywords Alzheimers disease, clinical trial, cognitive dysfunction, GLP-1 receptor agonist, neuroinflammation, neuroprotection, semaglutide, vascular dementia Citation Alhowail AH, Al Mouslem AK, Almatrafi MA and Aldubayan MA (2026) Semaglutide in cognitive dysfunction: neuroprotective potential, clinical trial limitations, and a prevention-focused framework
This test does not predict exact GLP-1 response and should not replace medical evaluation
LegitScript-verified platform connects patients with licensed providers for GLP-1 weight loss treatment, with transparent pricing, multiple pharmacy options, and no long-term contracts
An IV (intravenous) drip is a medical treatment that delivers fluids, vitamins, minerals, and other nutrients directly into your bloodstream through a vein
Comment on Shah and Ayala